best glp-1 agonist companies Agonists Market Report 2025-2033, By Product, Molecule, and Geo GLP-1 Drugs from the Gray
Description
FUNDING This work was supported by the National Natural Science Foundation of China (82300903), the Key R&D Plan Social Development Project of Jiangsu Province (SBE2023741128), the National Natural Science Foundationof Jiangsu Province (SBK20 23022865), the sixth phase 333 second level talent training project of Jiangsu Province (tackling bottleneck technology) (BRA2022008), the Projects from Social Development of Zhenjiang (SH2023029), the Youth Science and Technology Talent Recruitment Project of Zhenjiang city (ZJTJ2101), the Affiliated Hospital of Jiangsu University Beigu Talent Cultivation Plan Project (BGYCB202206), the Affiliated Hospital of Jiangsu University Doctoral Initiation Fund Project (jdfykc2021005)
Menopause weight gain
Millions of patients have used tirzepatide since 2022, providing real-world safety data beyond what controlled trials capture
Furthermore, the two groups had no evidence of a difference in mortality rate (HR 1.06
2024 doi: 10.1016/j.cgh.2024.03.013
